
Abiomed Inc (ABMD) - Product Pipeline Analysis, 2022 Update
Description
Summary
Abiomed Inc (Abiomed) is a medical device company that develops, manufactures and markets circulatory support devices. The devices replace or assist the pumping function in a failing heart. The company’s heart support and recovery product portfolio includes Impella heart pumps (catheter-based devices including micro heart pumps, expandable catheter pumps and axial flow pumps) and Breethe system (implantable cardiac and respiratory assist devices). Abiomed also offers online clinical support through Impella Connect, on-call assistance and on-site assistance for health workers in hospitals. The company sells its products through direct sales and distributors in South America, Europe, Asia, and the Middle East. Abiomed is headquartered in Danvers, Massachusetts, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
Abiomed Inc (Abiomed) is a medical device company that develops, manufactures and markets circulatory support devices. The devices replace or assist the pumping function in a failing heart. The company’s heart support and recovery product portfolio includes Impella heart pumps (catheter-based devices including micro heart pumps, expandable catheter pumps and axial flow pumps) and Breethe system (implantable cardiac and respiratory assist devices). Abiomed also offers online clinical support through Impella Connect, on-call assistance and on-site assistance for health workers in hospitals. The company sells its products through direct sales and distributors in South America, Europe, Asia, and the Middle East. Abiomed is headquartered in Danvers, Massachusetts, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Abiomed Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
44 Pages
- Abiomed Inc Company Overview
- Abiomed Inc Company Snapshot
- Abiomed Inc Pipeline Products and Ongoing Clinical Trials Overview
- Abiomed Inc – Pipeline Analysis Overview
- Business Description
- Abiomed Inc - Key Facts
- Abiomed Inc - Major Products and Services
- Abiomed Inc Pipeline Products by Development Stage
- Abiomed Inc Ongoing Clinical Trials by Trial Status
- Abiomed Inc Pipeline Products Overview
- AbioCor II
- AbioCor II Product Overview
- Abiomed Breethe OXY-1 System
- Abiomed Breethe OXY-1 System Product Overview
- Artificial Intelligence Algorithm
- Artificial Intelligence Algorithm Product Overview
- Expandable Sheath - Heart Failure
- Expandable Sheath - Heart Failure Product Overview
- Impecmo
- Impecmo Product Overview
- Impella BTR
- Impella BTR Product Overview
- Impella BTR Clinical Trial
- Impella ECP
- Impella ECP Product Overview
- Impella ECP Clinical Trial
- Impella RP IJ
- Impella RP IJ Product Overview
- Impella XC
- Impella XC Product Overview
- Impella XR Sheath With Impella CP
- Impella XR Sheath With Impella CP Product Overview
- Next Generation Impella CP - STEMI
- Next Generation Impella CP - STEMI Product Overview
- Next Generation Impella CP - STEMI Clinical Trial
- Symphony Heart Pump
- Symphony Heart Pump Product Overview
- Abiomed Inc - Key Competitors
- Abiomed Inc - Key Employees
- Abiomed Inc - Key Employee Biographies
- Abiomed Inc - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Recent Developments
- Abiomed Inc, Recent Developments
- Jul 14, 2022: Abiomed First Quarter Fiscal 2023 Earnings and Conference Call Notification
- Apr 28, 2022: Abiomed Announces Fourth Quarter Record Revenue of $270 Million, up 12% Year Over Year
- Apr 08, 2022: Abiomed Fourth Quarter Fiscal 2022 Earnings and Conference Call Notification
- Mar 21, 2022: Abiomed to Host Investor Call on Impella ECP, the World’s Smallest Heart Pump at 9 French
- Feb 08, 2022: Abiomed to Present at the SVB Leerink 11th Annual Global Healthcare Conference
- Jan 14, 2022: Abiomed Third Quarter Fiscal 2022 Earnings and Conference Call Notification
- Nov 18, 2021: Abiomed to Present at Upcoming Investor Conferences
- Oct 28, 2021: Abiomed Announces Q2 FY 2022 Revenue of $248 Million, Up 18% Year Over Year
- Mar 04, 2021: MEDCERT enables the use of the single access procedure with Impella CP introducer sheaths in Europe
- Feb 17, 2021: Abiomed Announces Appointment of Dr. Myron Rolle to Board of Directors
- Appendix
- Methodology
- About GlobalData
- Contact Us
- Disclaimer
- List of Tables
- Table 1: Abiomed Inc Pipeline Products and Ongoing Clinical Trials Overview
- Table 2: Abiomed Inc Pipeline Products by Equipment Type
- Table 3: Abiomed Inc Pipeline Products by Indication
- Table 4: Abiomed Inc, Key Facts
- Table 5: Abiomed Inc, Major Products and Services
- Table 6: Abiomed Inc Number of Pipeline Products by Development Stage
- Table 7: Abiomed Inc Pipeline Products Summary by Development Stage
- Table 8: Abiomed Inc Ongoing Clinical Trials by Trial Status
- Table 9: Abiomed Inc Ongoing Clinical Trials Summary
- Table 10: AbioCor II - Product Status
- Table 11: AbioCor II - Product Description
- Table 12: Abiomed Breethe OXY-1 System - Product Status
- Table 13: Abiomed Breethe OXY-1 System - Product Description
- Table 14: Artificial Intelligence Algorithm - Product Status
- Table 15: Artificial Intelligence Algorithm - Product Description
- Table 16: Expandable Sheath - Heart Failure - Product Status
- Table 17: Expandable Sheath - Heart Failure - Product Description
- Table 18: Impecmo - Product Status
- Table 19: Impecmo - Product Description
- Table 20: Impella BTR - Product Status
- Table 21: Impella BTR - Product Description
- Table 22: Impella BTR - Use of the Impella BTR in Patients with Heart Failure: An Early Feasibility Study
- Table 23: Impella ECP - Product Status
- Table 24: Impella ECP - Product Description
- Table 25: Impella ECP - Use of the Impella ECP in Patients Undergoing an Elective High-risk Percutaneous Coronary Intervention: An Early Feasibility Study
- Table 26: Impella ECP - Use of the Impella ECP in Patients Undergoing an Elective or Urgent High-Risk Percutaneous Coronary Intervention
- Table 27: Impella RP IJ - Product Status
- Table 28: Impella RP IJ - Product Description
- Table 29: Impella XC - Product Status
- Table 30: Impella XC - Product Description
- Table 31: Impella XR Sheath With Impella CP - Product Status
- Table 32: Impella XR Sheath With Impella CP - Product Description
- Table 33: Next Generation Impella CP - STEMI - Product Status
- Table 34: Next Generation Impella CP - STEMI - Product Description
- Table 35: Next Generation Impella CP - STEMI - Primary Unloading and Delayed Reperfusion in St-elevation Myocardial Infarction: The STEMI-DTU Trial
- Table 36: Symphony Heart Pump - Product Status
- Table 37: Symphony Heart Pump - Product Description
- Table 38: Abiomed Inc, Key Employees
- Table 39: Abiomed Inc, Key Employee Biographies
- Table 40: Abiomed Inc, Subsidiaries
- Table 41: Glossary
- List of Figures
- Figure 1: Abiomed Inc Pipeline Products by Equipment Type
- Figure 2: Abiomed Inc Pipeline Products by Development Stage
- Figure 3: Abiomed Inc Ongoing Clinical Trials by Trial Status
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.